|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.00 GBX | -1.39% |
|
+5.19% | +22.41% |
| 24/02 | Avacta hails new data supporting proprietary preCision platform | AN |
| 24/02 | Avacta Therapeutics Plans FAP-Exd's Clinical Trials After 'Favorable' Experimental Analysis | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 72 | 82.5 | 81.4 |
| Spread/Res. | -1.39% | -13.94% | -12.78% |
| Spread/Supp. | +15.45% | +43.43% | +54.35% |
| Support | 61.5 | 49.5 | 46 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AVCT Stock
- Charts Avacta Group Plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition